K
5.00
-1.89 (-27.43%)
| Previous Close | 6.89 |
| Open | 6.87 |
| Volume | 350,053 |
| Avg. Volume (3M) | 722,137 |
| Market Cap | 56,679,956 |
| Price / Sales | 264.74 |
| Price / Book | 3.09 |
| 52 Weeks Range | |
| Earnings Date | 28 May 2025 - 29 May 2025 |
| Operating Margin (TTM) | -42,029.54% |
| Diluted EPS (TTM) | -29.16 |
| Quarterly Revenue Growth (YOY) | 557,150.00% |
| Total Debt/Equity (MRQ) | 6.82% |
| Current Ratio (MRQ) | 0.210 |
| Operating Cash Flow (TTM) | -11.67 M |
| Levered Free Cash Flow (TTM) | -6.16 M |
| Return on Assets (TTM) | -85.55% |
| Return on Equity (TTM) | -3,891.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Kazia Therapeutics Limited | Bullish | Bullish |
AIStockmoo Score
-0.3
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.25 |
|
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 10.09% |
| % Held by Institutions | 8.22% |
| 52 Weeks Range | ||
| Median | 18.00 (260.00%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 12 Dec 2025 | 18.00 (260.00%) | Buy | 10.43 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |